146 related articles for article (PubMed ID: 36197773)
1. Crosstalk between CD93, C1q and GIPC in the Regulation of Pneumococcal Meningitis Inflammation.
Qiao N; Zhang J; Zhang Y; Liu X
Ann Clin Lab Sci; 2022 Jul; 52(4):634-641. PubMed ID: 36197773
[TBL] [Abstract][Full Text] [Related]
2. Synergistic regulation of microglia differentiation by CD93 and integrin β1 in the rat pneumococcal meningitis model.
Qiao N; Zhang J; Zhang Y; Liu X
Immunol Lett; 2022 Dec; 251-252():63-74. PubMed ID: 36336138
[TBL] [Abstract][Full Text] [Related]
3. Membrane-associated CD93 regulates leukocyte migration and C1q-hemolytic activity during murine peritonitis.
Greenlee-Wacker MC; Briseño C; Galvan M; Moriel G; Velázquez P; Bohlson SS
J Immunol; 2011 Sep; 187(6):3353-61. PubMed ID: 21849679
[TBL] [Abstract][Full Text] [Related]
4. CD93 and GIPC expression and localization during central nervous system inflammation.
Liu C; Cui Z; Wang S; Zhang D
Neural Regen Res; 2014 Nov; 9(22):1995-2001. PubMed ID: 25598782
[TBL] [Abstract][Full Text] [Related]
5. CD93 interacts with the PDZ domain-containing adaptor protein GIPC: implications in the modulation of phagocytosis.
Bohlson SS; Zhang M; Ortiz CE; Tenner AJ
J Leukoc Biol; 2005 Jan; 77(1):80-9. PubMed ID: 15459234
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD93 in allergic asthma.
Park HJ; Oh EY; Han HJ; Park KH; Jeong KY; Park JW; Lee JH
Sci Rep; 2020 Jan; 10(1):323. PubMed ID: 31941986
[TBL] [Abstract][Full Text] [Related]
7. Detection and characterization of soluble CD93 released during inflammation.
Greenlee MC; Sullivan SA; Bohlson SS
Inflamm Res; 2009 Dec; 58(12):909-19. PubMed ID: 19603257
[TBL] [Abstract][Full Text] [Related]
8. Human C1qRp is identical with CD93 and the mNI-11 antigen but does not bind C1q.
McGreal EP; Ikewaki N; Akatsu H; Morgan BP; Gasque P
J Immunol; 2002 May; 168(10):5222-32. PubMed ID: 11994479
[TBL] [Abstract][Full Text] [Related]
9. Murine CD93 (C1qRp) contributes to the removal of apoptotic cells in vivo but is not required for C1q-mediated enhancement of phagocytosis.
Norsworthy PJ; Fossati-Jimack L; Cortes-Hernandez J; Taylor PR; Bygrave AE; Thompson RD; Nourshargh S; Walport MJ; Botto M
J Immunol; 2004 Mar; 172(6):3406-14. PubMed ID: 15004139
[TBL] [Abstract][Full Text] [Related]
10. Augmented production of soluble CD93 in patients with systemic sclerosis and clinical association with severity of skin sclerosis.
Yanaba K; Asano Y; Noda S; Akamata K; Aozasa N; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Tada Y; Sugaya M; Kadono T; Sato S
Br J Dermatol; 2012 Sep; 167(3):542-7. PubMed ID: 22540233
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD93 induces differentiation of monocytes and enhances TLR responses.
Jeon JW; Jung JG; Shin EC; Choi HI; Kim HY; Cho ML; Kim SW; Jang YS; Sohn MH; Moon JH; Cho YH; Hoe KL; Seo YS; Park YW
J Immunol; 2010 Oct; 185(8):4921-7. PubMed ID: 20861352
[TBL] [Abstract][Full Text] [Related]
12. Soluble CD93 Is Involved in Metabolic Dysregulation but Does Not Influence Carotid Intima-Media Thickness.
Strawbridge RJ; Hilding A; Silveira A; Österholm C; Sennblad B; McLeod O; Tsikrika P; Foroogh F; Tremoli E; Baldassarre D; Veglia F; Rauramaa R; Smit AJ; Giral P; Kurl S; Mannarino E; Grossi E; Syvänen AC; Humphries SE; de Faire U; Östenson CG; Maegdefessel L; Hamsten A; Bäcklund A;
Diabetes; 2016 Oct; 65(10):2888-99. PubMed ID: 27659228
[TBL] [Abstract][Full Text] [Related]
13. C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis.
Lood C; Gullstrand B; Truedsson L; Olin AI; Alm GV; Rönnblom L; Sturfelt G; Eloranta ML; Bengtsson AA
Arthritis Rheum; 2009 Oct; 60(10):3081-90. PubMed ID: 19790049
[TBL] [Abstract][Full Text] [Related]
14. Immune function of C1q and its modulators CD91 and CD93.
Tarr J; Eggleton P
Crit Rev Immunol; 2005; 25(4):305-30. PubMed ID: 16167883
[TBL] [Abstract][Full Text] [Related]
15. Structure-function studies of the receptors for complement C1q.
McGreal E; Gasque P
Biochem Soc Trans; 2002 Nov; 30(Pt 6):1010-4. PubMed ID: 12440963
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric identification of CD93 expression on naive T lymphocytes (CD4(+)CD45RA (+) cells) in human neonatal umbilical cord blood.
Ikewaki N; Yamao H; Kulski JK; Inoko H
J Clin Immunol; 2010 Sep; 30(5):723-33. PubMed ID: 20512406
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of endothelial cell binding proteins/receptors for complement component C1q by inflammatory cytokines.
Guo WX; Ghebrehiwet B; Weksler B; Schweitzer K; Peerschke EI
J Lab Clin Med; 1999 Jun; 133(6):541-50. PubMed ID: 10360628
[TBL] [Abstract][Full Text] [Related]
18. Decrease in CD93 (C1qRp) expression in a human monocyte-like cell line (U937) treated with various apoptosis-inducing chemical substances.
Ikewaki N; Tamauchi H; Inoko H
Microbiol Immunol; 2007; 51(12):1189-200. PubMed ID: 18094537
[TBL] [Abstract][Full Text] [Related]
19. Soluble CD93 is an apoptotic cell opsonin recognized by α
Blackburn JWD; Lau DHC; Liu EY; Ellins J; Vrieze AM; Pawlak EN; Dikeakos JD; Heit B
Eur J Immunol; 2019 Apr; 49(4):600-610. PubMed ID: 30656676
[TBL] [Abstract][Full Text] [Related]
20. CD93 a potential player in cytotrophoblast and endothelial cell migration.
Fantone S; Tossetta G; Di Simone N; Tersigni C; Scambia G; Marcheggiani F; Giannubilo SR; Marzioni D
Cell Tissue Res; 2022 Jan; 387(1):123-130. PubMed ID: 34674045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
